MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q4 EPS of $0.23, $0.44 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.